SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported second-quarter net income of $333 million.
On a per-share basis, the Silver Spring, Maryland-based company said it had profit of $7.27.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $6.82 per share.
The drugmaker posted revenue of $783.3 million in the period, which missed Street forecasts. Five analysts surveyed by Zacks expected $803.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
